Biotron Secures $4.7 Million Underwriting Agreement 17 October 2018 by Audrey Thomson Biotron Secures $4.7 Million Underwriting Agreement
Appendix 3B – New Issue Announcement 11 October 2018 by Audrey Thomson Appendix 3B – New Issue Announcement
Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial 28 September 2018 by Audrey Thomson Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial
Appendix 4G and Corporate Governance Statement 29 August 2018 by Audrey Thomson Appendix 4G and Corporate Governance Statement 2018
Year End Accounts and Preliminary Final Report 29 August 2018 by Audrey Thomson Year End Accounts and Preliminary Final Report
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial 7 August 2018 by Justine Bednorz Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
